| 中国学者近期发表的论文 |
|---|
| 1. | Impaired immunomodulatory function of chronic myeloid leukemia cancer stem cells and the possible mechanism involved in it.
Author: Xishan Z, Xinna Z, Baoxin H, Jun R.
Journal: Cancer Immunol Immunother. 2013 Apr;62(4):689-703. doi: 10.1007/s00262-012-1367-5. Epub 2012 Nov 21. | | 2. | TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4(+)CD25 (+) Treg apoptosis.
Author: Diao Z, Shi J, Zhu J, Yuan H, Ru Q, Liu S, Liu Y, Zheng D.
Journal: Cancer Immunol Immunother. 2013 Apr;62(4):653-63. doi: 10.1007/s00262-012-1370-x. Epub 2012 Nov 11. | | 3. | Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance.
Author: Zhang XW, Qin X, Qin CY, Yin YL, Chen Y, Zhu HL.
Journal: Cancer Immunol Immunother. 2013 Mar;62(3):563-70. doi: 10.1007/s00262-012-1361-y. Epub 2012 Oct 23. | | 4. | Higher numbers of T-bet(+) intratumoral lymphoid cells correlate with better survival in gastric cancer.
Author: Chen LJ, Zheng X, Shen YP, Zhu YB, Li Q, Chen J, Xia R, Zhou SM, Wu CP, Zhang XG, Lu BF, Jiang JT.
Journal: Cancer Immunol Immunother. 2013 Mar;62(3):553-61. doi: 10.1007/s00262-012-1358-6. Epub 2012 Oct 23. | | 5. | Up-regulation of Foxp3 participates in progression of cervical cancer.
Author: Zeng C, Yao Y, Jie W, Zhang M, Hu X, Zhao Y, Wang S, Yin J, Song Y.
Journal: Cancer Immunol Immunother. 2013 Mar;62(3):481-7. doi: 10.1007/s00262-012-1348-8. Epub 2012 Sep 18. | | 6. | Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.
Author: Yao Y, Yuan D, Liu H, Gu X, Song Y.
Journal: Cancer Immunol Immunother. 2013 Mar;62(3):471-9. doi: 10.1007/s00262-012-1347-9. Epub 2012 Sep 18. | | 7. | Sinomenine hydrochloride enhancement of the inhibitory effects of anti-transferrin receptor antibody-dependent on the COX-2 pathway in human hepatoma cells.
Author: Hong Y, Yang J, Shen X, Zhu H, Sun X, Wen X, Bian J, Hu H, Yuan L, Tao J, Lei P, Shen G.
Journal: Cancer Immunol Immunother. 2013 Mar;62(3):447-54. doi: 10.1007/s00262-012-1337-y. Epub 2012 Sep 2. | | 8. | Identification of a novel HLA-A2-restricted mutated Survivin epitope and induction of specific anti-HCC CTLs that could effectively cross-recognize wild-type Survivin antigen.
Author: Shen H, Shao HW, Chen XH, Wu FL, Wang H, Huang ZL, Shen J, Wang T, Zhang WF, Huang SL.
Journal: Cancer Immunol Immunother. 2013 Feb;62(2):393-403. doi: 10.1007/s00262-012-1323-4. Epub 2012 Aug 29. | | 9. | The antitumor effect of the toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant.
Author: Huang YK, Zheng Z, Cheng CX, Wang LY, Li YR, Qiu F.
Journal: Cancer Immunol Immunother. 2013 Feb;62(2):237-44. doi: 10.1007/s00262-012-1328-z. Epub 2012 Aug 7. | | 10. | A knockdown of Maml1 that results in melanoma cell senescence promotes an innate and adaptive immune response.
Author: Kang S, Xie J, Miao J, Li R, Liao W, Luo R.
Journal: Cancer Immunol Immunother. 2013 Jan;62(1):183-90. doi: 10.1007/s00262-012-1318-1. Epub 2012 Aug 5. |
|
